Key result
Severe EV71 infection was associated with significantly lower frequencies of CD4+Foxp3+ T cells (26.3% vs 33.9%) and plasma cAMP levels compared to mild infection.
Why the study?
Does milrinone treatment improve regulatory T cell populations and cAMP expression in pediatric patients with severe EV71 infection?
Observational (n=41)
No
Does milrinone treatment improve regulatory T cell populations and cAMP expression in pediatric patients with severe EV71 infection?
Absolute Event Rate: 26.3% vs 33.9%
p-value: p=0.007
Milrinone treatment in severe EV71 infection is associated with increased regulatory T cell populations, elevated cAMP expression, and reduced pro-inflammatory cytokines.
Lower Treg frequencies and cAMP in severe EV71 support mechanistic studies; should not yet change practice.
BACKGROUND: Brainstem encephalitis (BE) and pulmonary edema (PE) are notable complications of enterovirus 71 (EV71) infection. OBJECTIVE: This study investigated the immunoregulatory characterizations of EV71 neurological complications by disease severity and milrinone treatment. STUDY DESIGN: Patients <18 years with virologically confirmed EV71 infections were enrolled and divided into 2 groups: the hand, foot, and mouth disease (HFMD) or BE group, and the autonomic nervous system (ANS) dysregulation or PE group. Cytokine and cyclic adenosine monophosphate (cAMP) levels, and the regulatory T cell (Tregs) profiles of the patients were determined. RESULTS: Patients with ANS dysregulation or PE exhibited significantly low frequency of CD4(+)CD25(+)Foxp3+ and CD4(+)Foxp3(+) T cells compared with patients with HFMD or BE. The expression frequency of CD4-CD8- was also significantly decreased in patients with ANS dysregulation or PE. Among patients with ANS dysregulation or PE, the expression frequency of CD4+Foxp3+ increased markedly after milrinone treatment, and was associated with reduction of plasma levels IL-6, IL-8 and IL-10. Plasma concentrations of cAMP were significantly decreased in patients with ANS dysregulation or PE compared with patients with HFMD or BE; however, cAMP levels increased after milrinone treatment. CONCLUSIONS: These findings suggested decreased different regulatory T populations and cAMP expression correlate with increased EV71 disease severity. Improved outcome after milrinone treatment may associate with increased regulatory T populations, cAMP expression and modulation of cytokines levels.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2014) conducted an observational in Enterovirus 71 (EV71) infection (n=41). Severe EV71 infection (ANS dysregulation or pulmonary edema) vs. Mild EV71 infection (HFMD or uncomplicated brainstem encephalitis) was evaluated on CD4+Foxp3+ T cell expression frequency (p=0.007). Severe EV71 infection was associated with significantly lower frequencies of CD4+Foxp3+ T cells (26.3% vs 33.9%) and plasma cAMP levels compared to mild infection.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: